Abstract:The purpose of this study was to develop and evaluate a novel amorphous solid dispersion system for tectorigenin (TG). TG is one of isoflavone aglycones extracted from Iris tectorum and flowers of Pueraria thunbergiana , but its poor water solubility and low membrane permeability have severely restricted the clinical application. To increase the aqueous solubility and oral bioavailability of TG, we prepared the solid dispersions of tectorigenin (TG-SD) using a simple solvent evaporation process with TG, polyvinylpyrrolidone (PVP) and PEG4000 at weight ratio of 7:54:9 after tested in several ratios. The prepared solid dispersions of tectorigenin are duly characterized for drug morphological conversion, in vitro dissolution and in vivo bioavailability. The X-ray diffraction (XRD), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) studies have indicated the morphological conversion of tectorigenin to amorphous form. In vitro release profiles revealed that the % release of TG-SD was achieved 4.35-fold higher than that of the pure drug after 150 min. The oral bioavailability of the solid dispersion in rats was also increased based on AUC 0–t and C max of TG-SD, which were 4.8- and 13.1-fold higher than that of TG crystal, respectively. It is worth noting that physical mixture containing TG, PEG 4000 and PVP produced a similar level of oral exposure as TG-SD, suggesting that PEG 4000 and PVP were able to enhance bioavailability of TG in rats. However, with the reduction of particle size, TG-SD provided the fastest oral absorption compared to physical mixture and pure drug. These results demonstrated that the efficacy of solid dispersions for the enhancement of TG oral bioavailability was by increasing its aqueous solubility and the solid dispersion formulation could be a viable option for enhancing the oral bioavailability of TG.

[Study on Solid Dispersion of Copovidone-Based Tanshinone II(A)].

Study on solid dispersion of binary vector of tanshinone II A]

Influence of solid dispersion technique combination on dissolution of tanshinone IIA]

Preparation of Cryptotanshinone Solid Dispersion and Its Properties

Preparation and physicochemical characterizations of tanshinone IIA solid dispersion

Novel Tanshinone II A Ternary Solid Dispersion Pellets Prepared by a Single-Step Technique: in Vitro and in Vivo Evaluation

Enhanced Dissolution and Stability of Tanshinone IIA Base by Solid Dispersion System with Nano-Hydroxyapatite.

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

An Attempt to Stabilize Tanshinone IIA Solid Dispersion by the Use of Ternary Systems with Nano-Caco3 and Poloxamer 188.

[Comparison of Different Preparation Methods of Tanshinoneporous Silica Solid Dispersion].

Improvement in Oral Bioavailability and Dissolution of Tanshinone IIA by Preparation of Solid Dispersions with Porous Silica

Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.

Preparation and quality evaluation of tanshinone ⅡA self nano emulsifying drug delivery system

Effect of spray drying process on physical properties and dissolution of tanshinone

Preparation and In Vitro Evaluation of Solid Dispersions of Total Flavones of Hippophae rhamnoides L.

Study on Xinyueshu spray drying assisted with copovidone and its effect on powder property

Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability

Studies on Preparation and in vitro Evaluation of Tacrolimus Solid Dispersions

Preparation and in Vitro Study of Solid Dispersions of Cyclosporine A

Study on the Preparation Technique of Tanshinone Dispersible Tablets

Preparation and Physicochemical Characterization of a Solid Dispersion of (3, 5, 6-Trimethylpyrazin-2-yl) Methyl 3-Methoxy-4-[(3, 5, 6-Trimethylpyrazin-2-yl) Methoxy] Benzoate (VA-T) and Polyvinylpyrrolidone